An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 7,594 | 6,932 | 4,998 | 2,050 | 0 |
Operating Income | -7,594 | -6,932 | -4,998 | -2,050 | N/A |
Other Income | 49 | -11 | -9 | 2 | 0 |
Pre-tax Income | -7,545 | -6,943 | -5,007 | -2,048 | 0 |
Net Income Continuous | -7,545 | -6,943 | -5,007 | -2,048 | N/A |
Net Income | $-7,545 | $-6,943 | $-5,007 | $-2,048 | $N/A |
EPS Basic Total Ops | -3.60 | -3.35 | -2.62 | -1.07 | N/A |
EPS Basic Continuous Ops | -2.86 | -2.63 | -1.90 | -0.78 | N/A |
EPS Diluted Total Ops | -3.60 | -3.35 | -2.62 | -1.07 | N/A |
EPS Diluted Continuous Ops | -2.86 | -2.63 | -1.90 | -0.78 | N/A |
EBITDA(a) | $-7,571 | $-6,913 | $-4,998 | $-2,050 | $N/A |